SCHEMBL28048792

SCHEMBL28048792

Cc1ccc(-c2ccnc(C(N)=O)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
KMO O15229 9/20 0.51
MAP4K4 O95819 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.45
RAB9A P51151 2/20 0.43
ALDH1A1 P00352 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NTRK1 P04629 1/20 0.43
PIM1 P11309 1/20 0.43
KDM4E B2RXH2 1/20 0.42
PRNP P04156 1/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
GFER P55789 1/20 0.42
IKBKB O14920 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28048743 0.85 KMO (0.71) MEN1KMT2AKMOSMN1; SMN2
SCHEMBL31301427 0.85 KMO (0.71) MEN1KMT2AKMOSMN1; SMN2
SCHEMBL28048742 0.83 KMO (0.55) MEN1KMT2AKMOMAP4K4SMN1; SMN2
SCHEMBL3183738 0.83 MAPK8 (0.55) MEN1KMT2AKMOMAP4K4KDM4E
SCHEMBL3454018 0.83 KMO (0.51) MEN1KMT2AKMOMAP4K4KDM4E
SCHEMBL3721991 0.80 KMO (0.53) KMT2AKMOMAP4K4IKBKB
SCHEMBL3133736 0.79 MAPT (0.52) MEN1KMT2AKMOSMN1; SMN2ALDH1A1
SCHEMBL30661019 0.78 KMO (0.46) MEN1KMT2AKMOSMN1; SMN2
SCHEMBL31301465 0.77 HSD17B1 (0.49) MEN1KMT2AKMOSMN1; SMN2KDM4E
SCHEMBL3125837 0.76 SCN9A (0.55) MEN1KMT2AL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105153026-A Biaryl amide structure containing sorafenib derivative as well as preparation method and applications thereof UNIV JIANGXI NORMAL SCI & TECH 2015-12-16 CN disclosed